Difference between revisions of "Reactive changes"
Jump to navigation
Jump to search
(3 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
# Inflammation. | # Inflammation. | ||
# Nuclear changes compatible with inflammation. | # Nuclear changes compatible with inflammation. | ||
# The absence of both neoplasia ''and'' the | # The absence of both neoplasia ''and'' the suspicion of neoplasia, i.e. it implies benignancy. | ||
'''Reactive inflammatory changes''' and '''inflammatory changes''' can be considered synonyms. | '''Reactive inflammatory changes''' and '''inflammatory changes''' can be considered synonyms. | ||
Line 26: | Line 26: | ||
*Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic). | *Inflammation - any type (e.g. [[neutrophil|neutrophilic]], [[plasma cells|plasmacytic]], lymphoplasmacytic). | ||
*+/-Proliferation (e.g. mitotic figures) or changes suggestive of proliferation (e.g. hyperplasia). | *+/-Proliferation (e.g. mitotic figures) or changes suggestive of proliferation (e.g. hyperplasia). | ||
Notes: | |||
*Cytoplasmic changes may be present. | |||
DDx: | DDx: | ||
Line 32: | Line 35: | ||
**Terminology dependent on the anatomical site, e.g. [[indefinite for dysplasia]], [[ASCUS]], [[ASAP]]. | **Terminology dependent on the anatomical site, e.g. [[indefinite for dysplasia]], [[ASCUS]], [[ASAP]]. | ||
*[[Nuclear atypia]]. | *[[Nuclear atypia]]. | ||
**This is often qualified as it may represent neoplastic process or a benign process | **This is often qualified as it may represent a neoplastic process or a benign process. | ||
**Common qualifiers: | **Common qualifiers: | ||
***Worrisome lesions: "cannot exclude dysplasia", "suspicious for malignancy". | ***Worrisome lesions: "... cannot exclude dysplasia", "... cannot exclude malignancy", "... suspicious for malignancy". | ||
***Suspected to be benign: "favour benign". | ***Suspected to be benign: "... favour benign". | ||
*[[Malignancy]]. | *[[Malignancy]]. | ||
Line 43: | Line 46: | ||
*[[NC ratio]]. | *[[NC ratio]]. | ||
*[[Reactive squamous epithelium of the uterine cervix]]. | *[[Reactive squamous epithelium of the uterine cervix]]. | ||
*[[Reactive astrocytes]]. | |||
[[Category:Stuff]] | [[Category:Stuff]] |
Latest revision as of 18:28, 31 July 2016
Reactive changes is a commonly used term in pathology that implies:
- Inflammation.
- Nuclear changes compatible with inflammation.
- The absence of both neoplasia and the suspicion of neoplasia, i.e. it implies benignancy.
Reactive inflammatory changes and inflammatory changes can be considered synonyms.
General
Nuclear changes are seen in:
- Inflammatory processes.
- Repair.
- Neoplastic processes, i.e. pre-cancerous conditions (e.g. dysplasia) and cancer.
Significance of nuclear changes in inflammation:
- The line between a reactive process and a neoplastic process may be fuzzy, i.e. it may be very difficult to be certain whether something is benign or malignant.
Consequence:
- In the context of inflammation, nuclear changes are typically present and the threshold for calling suspicious for malignancy or malignancy is typically higher.
Microscopic
Features - generic:
- Nuclear changes - typically:
- Nuclear enlargement.
- Nuclear hyperchromasia.
- Prominent nucleoli.
- Inflammation - any type (e.g. neutrophilic, plasmacytic, lymphoplasmacytic).
- +/-Proliferation (e.g. mitotic figures) or changes suggestive of proliferation (e.g. hyperplasia).
Notes:
- Cytoplasmic changes may be present.
DDx:
- Normal.
- Waffle diagnosis - nuclear changes of unknown significance.
- Terminology dependent on the anatomical site, e.g. indefinite for dysplasia, ASCUS, ASAP.
- Nuclear atypia.
- This is often qualified as it may represent a neoplastic process or a benign process.
- Common qualifiers:
- Worrisome lesions: "... cannot exclude dysplasia", "... cannot exclude malignancy", "... suspicious for malignancy".
- Suspected to be benign: "... favour benign".
- Malignancy.